James Kihara
PRINCIPAL ACCOUNTING OFFICER · 6 filings · Latest: Jun 26, 2026
ACADIA PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | Jun 26, 2026 | Sale | $26.08 | 11,421 | $297.9K | 13,088 | |
ACAD | Kihara James | — | Jun 26, 2026 | Proposed Sale | $26.00 | 11,421 | $297.0K | — | |
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | May 26, 2026 | Sale | $21.18 | 5,401 | $114.4K | 24,509 | |
ACAD | JAMES K KIHARA | — | May 26, 2026 | Proposed Sale | $21.18 | 5,401 | $114.4K | — | |
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | May 4, 2026 | Sale | $21.79 | 1,332 | $29.0K | 29,129 | |
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | May 1, 2026 | Option Exercise | — | 2,596 | — | 30,461 | |
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | Apr 7, 2026 | Sale | $22.20 | 1,030 | $22.9K | 27,865 | |
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | Apr 5, 2026 | Option Exercise | — | 2,010 | — | 28,895 | |
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | Mar 26, 2026 | Sale | $21.65 | 1,109 | $24.0K | 26,885 | |
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | Mar 25, 2026 | Option Exercise | — | 2,142 | — | 27,994 | |
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | Mar 25, 2026 | Sale | $21.47 | 833 | $17.9K | 25,852 | |
ACAD | James Kihara | PRINCIPAL ACCOUNTING OFFICER | Mar 24, 2026 | Option Exercise | — | 1,627 | — | 26,685 | |
ACAD | Kihara James | — | May 16, 2025 | Proposed Sale | $17.60 | 4,000 | $70.4K | — |